Hip bone graft may boost shoulder fracture recovery
NCT ID NCT07538700
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a piece of donated hip bone (femoral allograft) to standard plate surgery helps people aged 40-70 recover better from severe shoulder fractures. Half the participants will get the graft plus a plate, the other half just the plate. Researchers will compare shoulder function, pain, and quality of life over two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
femoral allograft (hip bone graft) used alongside locking plate fixation
What this could lead to
If it works, this could provide a better surgical option for severe shoulder fractures, leading to improved function and quality of life.
What could go wrong
This is a small, early-stage trial with only 56 participants, so results may not apply to everyone. Adding a bone graft also carries risks like infection or graft failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROXIMAL HUMERAL FRACTURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tergooi Medical Center
RECRUITINGHilversum, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••